The impact of bridging therapy prior to CD19-directed chimeric antigen receptor T-cell therapy in patients with large B-cell lymphoma

Forat Lutfi, Noa G. Holtzman, Ankit J. Kansagra, Moaath Mustafa Ali, Ali Bukhari, Jingsheng Yan, Santanu Samanta, David Gottlieb, Dong W. Kim, Lisa R. Matsumoto, Natalie Gahres, Kathleen Ruehle, Seung T. Lee, Jennie Y. Law, Mehmet H. Kocoglu, Djordje Atanackovic, Jean A. Yared, Nancy M. Hardy, Jason Molitoris, Pranshu MohindraAaron P. Rapoport, Saurabh Dahiya